Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-β signaling by sequestration of the Smad proteins

^†Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720; ^§Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720; and ^‡Institut National de la Santé et de la Recherche Médicale, Unité 697, Pavillon Bazon, Hôpital Saint-Louis, 75010 Paris, France

Edited by Joan S. Brugge, Harvard Medical School, Boston, MA, and approved July 8, 2005 (received for review May 19, 2005)

Abstract

TGF-β is a ubiquitously expressed cytokine that signals through the Smad proteins to regulate many diverse cellular processes. SnoN is an important negative regulator of Smad signaling. It has been described as a nuclear protein, based on studies of ectopically expressed SnoN and endogenous SnoN in cancer cell lines. In the nucleus, SnoN binds to Smad2, Smad3, and Smad4 and represses their ability to activate transcription of TGF-β target genes through multiple mechanisms. Here, we show that, whereas SnoN is localized exclusively in the nucleus in cancer tissues or cells, in normal tissues and nontumorigenic or primary epithelial cells, SnoN is predominantly cytoplasmic. Upon morphological differentiation or cell-cycle arrest, SnoN translocates into the nucleus. In contrast to nuclear SnoN that represses the transcriptional activity of the Smad complexes, cytoplasmic SnoN antagonizes TGF-β signaling by sequestering the Smad proteins in the cytoplasm. Interestingly, cytoplasmic SnoN is resistant to TGF-β-induced degradation and therefore is more potent than nuclear SnoN in repressing TGF-β signaling. Thus, we have identified a mechanism of regulation of TGF-β signaling via differential subcellular localization of SnoN that is likely to produce different patterns of downstream TGF-β responses and may influence the proliferation or differentiation states of epithelial cells.

Footnotes

↵ ¶ To whom correspondence should be addressed at: Department of Molecular Cell Biology, University of California, 16 Barker Hall, MC3204, Berkeley, CA 94720. E-mail: kluo{at}berkeley.edu.
Author contributions: K.L. designed research and analyzed data; A.R.K. and J.L. performed research; A.M. and M.J.B. contributed new reagents/analytic tools and provided discussion of the project and critical reading and revision of the manuscript; and A.R.K. and K.L. wrote the paper.
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: HA, hemagglutinin; ECM, extracellular matrix; HEKa, adult human epidermal keratinocytes.